“Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.”, Biol Blood Marrow Transplant, vol. 18, no. 9, pp. 1368-77, 2012.
, “A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.”, Biol Blood Marrow Transplant, vol. 20, no. 3, pp. 326-36, 2014.
,